AgomAb Therapeutics NV ADR (AGMB) has an average rating of buy and mean price target of $32.53, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Craig Hallum Downgrades BioLife Solutions to Hold From Buy
Maxim Downgrades BioLife Solutions to Hold From Buy
UDR (UDR) has an average rating of Hold and mean price target of $41.95, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $39.55, Change: $-0.02, Percent Change: -0.05%